Incannex is sooo much better fundamentally now than where the company stood when the SP was 70cts
Waiting on TGA approvals for the first clinic to commence PSI-GAD administration and therapy treatment 42X commencing phase 2-3 trial in the US which has blown standard conventional medicines used with excellent safety and efficiency record, 42X works in the manner intended and out of the bloodstream by morning. This is an exciting pathway and IMHO the first to commercialization. 675A results due in November and if positive, cementing the need for this type of dedicated clinical therapy industry will push Incannex front and center in the PSI world stage and excellent timing for Clarion. The Canquite program finalizing ethics approval with a projected $10bn opiod addiction market. Entering one of the biggest financial equity market world wide with all the above pathways TAM in the multi billions and against peer companies valued at multiples of IHL MC
IHL was a buy at 30cts, a great buy at 20cts and a no brainer at 10cts. Its been an absolute gift at 6-7cts and the SHers that took advantage of this period will be well rewarded. If the aims and objectives achieved so far by this management and team are reproduced in the near term and beyond we will look back at this redomicile period and thank the opportunity these last few months offered. GLAH
IHL Price at posting:
7.5¢ Sentiment: Hold Disclosure: Held
